Delivery Order SPE2DB24D1107-SPE2DB25FZGH1
- Not listed
- The Defense Logistics Agency awarded a $1,269.13 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $3,073.28 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Vyvanse 40 mg capsules (100 count) with a completion date of August 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $17.4K delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (40mg) under a firm fixed-price contract. The delivery order, issued on August 5, 2025, represents a non-competitive, competitively awarded transaction with a completion deadline of August 6, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery....
- The Defense Logistics Agency awarded a delivery order valued at $2,323.60 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,839.95 to AmerisourceBergen Drug Corp for the supply of 100 capsules of Vyvanse 40 mg. This competitive award, issued on August 12, 2025, with a completion date of August 13, 2025, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $1,547.46 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The order will be fulfilled from the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $3,140.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100 count) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,839.72 to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100 count) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyvanse 30 mg capsules (100-count) with a contract value of $2,117.56 and completion date of July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,337.70 to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100-count units) under a firm fixed-price contract. This non-set-aside award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction within AmerisourceBergen's broader federal...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGH1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 40 mg, valued at $1,422.26 under a firm fixed price contract type. This non-set-aside award was issued on August 19, 2025, with an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates consistent capability to meet competitive federal procurement requirements, with this specific order fulfilling pharmaceutical supply needs for the Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/19/25 |